Stay updated with breaking news from Nasdaq Afmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Affimed (NASDAQ:AFMD – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 2,160,000 shares, a decrease of 8.9% from the September 15th total of 2,370,000 shares. Based on an average daily volume of 485,400 shares, the days-to-cover […]
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research note released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. AFMD has been the subject of several other reports. Truist Financial reduced their target price on Affimed from $8.00 to $6.00 and set a buy […]
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently commented on AFMD. Truist Financial lowered their price target on Affimed from $8.00 to $6.00 and set a […]
Affimed (NASDAQ:AFMD – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among […]
Shares of Affimed (NASDAQ:AFMD – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective […]